㈜셀렌진

{
  "address": "경기도 성남시",
  "ceo_name": "안재형",
  "certificate": [
    {
      "cert_number": "20190301190",
      "changes": "",
      "disclosure_date": "2019-12-11",
      "first_cert_date": "2019-12-11",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2019-12-11 ~ 2021-12-10"
    },
    {
      "cert_number": "20211110010014",
      "changes": "",
      "disclosure_date": "2021-11-10",
      "first_cert_date": "2019-12-11",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2021-12-11 ~ 2024-12-10"
    },
    {
      "cert_number": "20241120010016",
      "changes": "",
      "disclosure_date": "2024-11-20",
      "first_cert_date": "2019-12-11",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2024-12-11 ~ 2027-12-10"
    }
  ],
  "company_name": "㈜셀렌진",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 641633000,
      "cost_of_sales": 0,
      "current_assets": 170600000,
      "current_liabilities": 17269000,
      "gross_profit": 0,
      "net_income": -1482087000,
      "net_income_bs": -1482087000,
      "non_current_assets": 230334000,
      "non_current_liabilities": 133060000,
      "non_operating_expenses": 266000,
      "non_operating_income": 1017000,
      "operating_profit": -1482838000,
      "revenue": 0,
      "sga_expenses": 1482838000,
      "total_assets": 400934000,
      "total_equity": 250605000,
      "total_liabilities": 150329000
    },
    "2023": {
      "capital_stock": 646033000,
      "cost_of_sales": 0,
      "current_assets": 115810000,
      "current_liabilities": 1130069000,
      "gross_profit": 0,
      "net_income": -1507684000,
      "net_income_bs": -1507684000,
      "non_current_assets": 197868000,
      "non_current_liabilities": 220688000,
      "non_operating_expenses": 38350000,
      "non_operating_income": 451000,
      "operating_profit": -1469785000,
      "revenue": 0,
      "sga_expenses": 1469785000,
      "total_assets": 313678000,
      "total_equity": -1037079000,
      "total_liabilities": 1350757000
    },
    "2024": {
      "capital_stock": 669584000,
      "cost_of_sales": 0,
      "current_assets": 89136000,
      "current_liabilities": 1907625000,
      "gross_profit": 0,
      "net_income": -1529111000,
      "net_income_bs": -1529111000,
      "non_current_assets": 175407000,
      "non_current_liabilities": 121792000,
      "non_operating_expenses": 43880000,
      "non_operating_income": 5543000,
      "operating_profit": -1490774000,
      "revenue": 0,
      "sga_expenses": 1490774000,
      "total_assets": 264543000,
      "total_equity": -1764874000,
      "total_liabilities": 2029417000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "1,500,000,000",
      "changes": "1,500,000,000",
      "date": "2020-11-19"
    },
    {
      "amount": "200,000,000",
      "changes": "200,000,000",
      "date": "2020-05-27"
    },
    {
      "amount": "50,000,000",
      "changes": "50,000,000",
      "date": "2019-12-04"
    }
  ],
  "main_products": "항암제 개발",
  "phone": "031-8023-****",
  "years": [
    2024,
    2023,
    2022
  ]
}